UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity

Obstetrics and gynecology (New York. 1953), 2012-01, Vol.119 (1), p.61-67

2012

Volltextzugriff (PDF)

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The lancet oncology, 2013-02, Vol.14 (2), p.134-140

2013

Volltextzugriff (PDF)

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Cancer, 2013-01, Vol.119 (2), p.325-331

2013

Volltextzugriff (PDF)

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153

2010

Volltextzugriff (PDF)

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5546-5553

2004

Volltextzugriff (PDF)

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer, 2011-06, Vol.117 (12), p.2643-2651

2011

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2003-04, Vol.55 (5), p.1272-1276

2003

Volltextzugriff (PDF)

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995

Obstetrics and gynecology (New York. 1953), 2001-02, Vol.97 (2), p.248-254

2001

Volltextzugriff (PDF)

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009-11, Vol.175 (5), p.2184-2196

2009

Volltextzugriff (PDF)

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1145-1153

2001

Volltextzugriff (PDF)

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Cancer, 2000-06, Vol.88 (12), p.2782-2786

2000

Volltextzugriff (PDF)

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Gynecologic oncology, 2001-09, Vol.82 (3), p.456-463

2001

Volltextzugriff (PDF)

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1154-1160

2001

Volltextzugriff (PDF)

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Gynecologic oncology, 1999-10, Vol.75 (1), p.72-77

1999

Volltextzugriff (PDF)

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

Outcome and Management of Pathological Stage I Endometrial Carcinoma Patients with Involvement of the Lower Uterine Segment

Gynecologic oncology, 2001-12, Vol.83 (3), p.513-517

2001

Volltextzugriff (PDF)

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2000-12, Vol.48 (5), p.1613-1621

2000

Volltextzugriff (PDF)

New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells

Cancer letters, 2008-12, Vol.272 (1), p.12-22

2008

Volltextzugriff (PDF)

Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment : Role of the microenvironment in tumor growth and metastasis

Cancer and metastasis reviews, 2008, Vol.27 (1), p.67-73

2008

Volltextzugriff (PDF)

Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine Serosa

Gynecologic oncology, 2001-08, Vol.82 (2), p.338-343

2001

Volltextzugriff (PDF)

Phase I Trial of Concomitant Vinorelbine, Paclitaxel, and Pelvic Irradiation in Cervical Carcinoma and Other Advanced Pelvic Malignancies

Gynecologic oncology, 2001-08, Vol.82 (2), p.333-337

2001

Volltextzugriff (PDF)

One versus Two Intracavitary Brachytherapy Applications in Early-Stage Cervical Cancer Patients Undergoing Definitive Radiation Therapy

Gynecologic oncology, 2000-07, Vol.78 (1), p.32-38

2000

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

ThemaOvarian Neoplasms - Pathology

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Assessing gynecologic and breast cancer survivors' sexual health care needs

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Outcome and Management of Pathological Stage I Endometrial Carcinoma Patients with Involvement of the Lower Uterine Segment

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells

Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment : Role of the microenvironment in tumor growth and metastasis

Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine Serosa

Phase I Trial of Concomitant Vinorelbine, Paclitaxel, and Pelvic Irradiation in Cervical Carcinoma and Other Advanced Pelvic Malignancies

One versus Two Intracavitary Brachytherapy Applications in Early-Stage Cervical Cancer Patients Undergoing Definitive Radiation Therapy

Aktive Filter

Suchergebnisse filtern